Skip to content

Oxylight

by RAJA Medical

Oxylight is a multi-modality skin surface treatment system (FDA Class II) made by RAJA Medical, cleared under FDA 510(k) K202175 on 2 Dec 2021 (1 earlier submission) and listed in FDA GUDID since 9 Sep 2021 (UDI-DI G050OXYLIGHT0), active as of 23 Oct 2026.

Active United States. Also listed in GUDID (US).

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 23 Oct 2026

Documents

Trust

Unverified

Source GUDID, synced 23 Oct 2026.

Regulatory status

as of registry sync 23 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE from GUDID Substantially Equivalent · Traditional NumberK202175 Date2 Dec 2021DecidedStatusActive
United StatesGUDID listing NumberG050OXYLIGHT0 UDI-DI Date9 Sep 2021ListedStatusListed GUDID: in commercial distribution

Official records

From the FDA record

Device description
The OXYLIGHT System is a multi-modality skin surface treatment system that uses multiple therapeutic modalities delivered through different attachments or handles connected to a main body. The system includes an LED panel/ lamp that irradiates Blue, Red and Yellow LED light and Oxygen Spray. The system also includes various handles that deliver a variety of therapeutic modalities for skin rejuvenation.
MRI safety
Labeling does not contain MRI Safety Information
Natural rubber latex
No latex statement on the label
Sterility
Supplied non-sterile

From the GUDID record (AccessGUDID), as read on 23 Oct 2026, as the labeller entered it.

Across registries

2 registries list this device

  • FDA 510(k) K202175 decided 2 Dec 2021 Active· +1 more in the status table
  • FDA GUDID UDI-DI G050OXYLIGHT0 listed 9 Sep 2021 Listed

Timeline

3 dated events

  1. Cleared FDA 510(k) K200104
  2. Listed FDA GUDID G050OXYLIGHT0
  3. Cleared FDA 510(k) K202175

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

GUDID

Generic name
Multi-modality skin surface treatment system
Model / reference
OXYLIGHT
Primary DI / UDI-DI
G050OXYLIGHT0
510(k) Number
FDA product code
GEX, GFE
GMDN term
Multi-modality skin surface treatment system
Device class
Class II
Regulation number
878.4810, 878.4820
GUDID distribution status
In Commercial Distribution

Similar devices in this category

Other devices filed under Multi-modality skin surface treatment system.

Other devices from RAJA Medical

See all devices from RAJA Medical →

Properties

  • Prescription use
  • Serial number
Other properties (13, all answered No)